Hemant K. Rohera — biography and timeline
This is a biography assembled only from things a stranger can check: patent offices, a company register, a regulator, a medical index and a DOI registry. Every date below has a document behind it. What is not on the record is not on this page, and the last section says what that leaves out.
The short version
Independent inventor, based in Pune, Maharashtra, India. Three granted United States patents in three unrelated fields — vehicle power generation, hybrid energy storage and a bioelectronic medical device — all held personally rather than by any company. Three registered Indian companies that develop and commercialise those technologies. One review indexed in PubMed via PMC, and six technical notes deposited with registered DOIs.
The three name forms on the public record are Hemant K. Rohera, Hemant Karamchand Rohera and Hemant Rohera. They are one person, and the patent record itself is the reason there are three: why the record spells the name three ways.
The timeline, with the document behind each line
Dates are taken from the issuing authority in each case, not from a profile or a press item. Where a filing date and a grant date are both given, they are the United States application date and the United States issue date as they appear on the patent itself.
| Date | What happened | Where it is recorded |
|---|---|---|
| 2012–2019 | Director, Swatantra Power Private Limited | Ministry of Corporate Affairs |
| 11 August 2015 | United States application filed — Hybrid power pack | USPTO |
| 17 September 2016 | United States application filed — Power generating system and method for a vehicle | USPTO |
| 2018 | Rohera Industries (OPC) Private Limited incorporated, Pune | MCA — CIN U73100PN2018OPC174240 |
| 2018 | Rohera Emerging Energies Private Limited incorporated, Pune | MCA — CIN U29308PN2018PTC178170 |
| 31 December 2019 | US 10,523,019 B2 granted — Hybrid Power Pack | USPTO |
| 5 June 2020 | United States application filed — Medical therapeutic device | USPTO |
| 2020 | Rohera Healthcare & Technology Private Limited incorporated, Pune | MCA — CIN U33309PN2020PTC194671 |
| 14 September 2021 | US 11,117,476 B2 granted — OMNIA Drive | USPTO |
| 25 January 2023 | ZA 2022/04073 B granted — eMedica, South Africa | CIPC |
| 2023 | CDSCO Class A manufacturing licence MFG/MD/2023/000926 (Form MD-5) | FDA Maharashtra |
| 18 February 2025 | US 12,226,183 B2 granted — eMedica | USPTO |
| September 2025 | Review published in Cureus, PMID 41116920 | PubMed / PMC |
| 11 September 2026 | Six technical notes deposited on Zenodo with registered DOIs | Zenodo / DataCite |
What the order of those dates actually says
The energy work came first. The Hybrid power pack application was filed in August 2015 and the vehicle power-generation application thirteen months later, in September 2016. The medical device application came nearly four years after that, in June 2020. The companies follow the same order: the two energy companies in 2018, the healthcare company in 2020.
That order matters because the obvious objection to a portfolio spanning three unrelated fields is that it looks unfocused. The honest answer is that it is one method applied three times rather than three separate interests, and the common thread is electrical: what a current does when it is delivered in a controlled way rather than an uncontrolled one. In a battery pack that means putting a capacitor where the transient goes. In a vehicle it means conditioning power at source. In a medical device it means a microampere-level waveform with recited parameter ranges.
Three United States grants in three fields over ten years is a modest record by the standards of a corporate research department and an unusual one for an individual. Both of those things are true at once, and neither needs inflating.
The patents, held personally
The assignee field on all three granted United States patents reads Individual. The patents are not owned by any of the companies, and none of them sits on a corporate balance sheet. The consequences for chain of title and for licensing are set out in what "Individual" on the assignee line means and in the note on the three companies.
The portfolio runs to 2035, 2037 and 2041 on the United States grants. The full jurisdiction-by-jurisdiction position, with the lapsed and ceased entries named rather than quietly omitted, is on the patent register.
What this page does not claim
A biography is the easiest page on any site to inflate, so the limits are stated rather than left to inference.
- No years-of-experience figure is given. Numbers of that kind circulate in third-party write-ups about me; none of them has a document behind it, and I am not going to repeat one because it flatters.
- No patent count is given as a number. Jurisdictions are named on the register instead, because a count goes stale the moment one entry lapses.
- No award, ranking, honour or listing is claimed.
- No clinical claim is made anywhere for the medical device. What the regulatory record does and does not establish is set out in the eMedica questions page, where nine of the eighteen answers are no.
- No institutional affiliation, degree or employer is listed, because none is being asserted as part of the record. The work stands on the patents and the publications.
Originally published at https://hemantrohera.com/biography.html — this is a copy for readers of this blog. The canonical version, with structured data and the full identifier list, is on the hub.
Comments
Post a Comment